Scientific Journal of Al-Azhar Medical Faculty [Girls] [The]. 1998; 19 (2): 175-183
en Inglés
| IMEMR
| ID: emr-49665
ABSTRACT
This study included 19 patients suffering from advanced non-small cell lung cancer [NSCLC]. They were treated either with Vinorelbine-Cisplatinum; or Vinorelbine as a single agent for elderly patients, or those with poor performance status, or with renal impairment [9 cases]. Objective partial response was achieved in 5 cases [26%] with median duration of response for 25 weeks for the whole study group. The response was comparable in both treatment arms; with better tolerance in patients receiving Vinorelbine alone. This study demonstrates the efficiency of Vinorelbine in the treatment of advanced NSCLC either in combination with Cisplatinum, or as a single agent in elderly frail patients
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Anciano
/
Factores Estimulantes de Colonias
/
Cisplatino
/
Resultado del Tratamiento
/
Síndromes de Neurotoxicidad
/
Combinación de Medicamentos
/
Riñón
/
Neutropenia
Límite:
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Sci. J. Al-Azhar Med. Fac. [Girls]
Año:
1998
Similares
MEDLINE
...
LILACS
LIS